Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015
Thorsten Rieck(Robert Koch Institute), Ole Wichmann(Robert Koch Institute), Matthias an der Heiden(Robert Koch Institute), Marcel Feig(Robert Koch Institute), Anette Siedler(Robert Koch Institute)
Cited by 39
Related Papers
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
Neurological complications of dengue virus infection
|The Lancet Neurology|2013|500
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173